Civica targets 6 months of extra inventory, enabling it to buffer any supply shortage in the market.

The entity named CivicaScript builds on the mission of Civica to reach consumers directly with quality outpatient generic medicines that are affordable and available.

CivicaScript's price for the medication is approximately $3,000 per month less than the average cost for someone with Medicare Part D. In January 2021, Civica Rx announced its plans to build an essential medicines manufacturing facility in Virginia, part of a partnership with Virginia-based Phlow Corp to produce sterile injectable medications used in hospitals for COVID-19 patient care, emergency room and intensive-care unit treatments, surgeries, and to treat other serious conditions.

[4] Civica is a key collaborator in the U.S. government-funded partnership with Phlow Corp, Medicines for All Institute at Virginia Commonwealth University and AMPAC Fine Chemicals.

Gavin Newsom (D) announced a $50M 10-year deal with Civica to provide affordable insulin (vials and pre-filled pen cartridges) to residents, part of the state's broader CalRx initiative to offer prescription drugs at low cost for all Californians.